Brokerage Firm Rating Update on CVS Health Corporation (CVS)

CVS Health Corporation (CVS) : The consensus on CVS Health Corporation (CVS) based on 20 analyst recommendation on the company stock is 1.45, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 15 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

CVS Health Corporation (CVS) : 21 investment research analysts covering CVS Health Corporation (CVS) have an average price target of $111.88 for the near short term. The highest target price given by the Brokerage Firm to the stock is $123 and the lowest target is $90 for the short term. Analysts expect the variance to be within $7.5 of the average price.


For the current week, the company shares have a recommendation consensus of Buy. Also, Brokerage firm Citigroup maintains its rating on CVS Health Corporation (NYSE:CVS). As per the latest information, the brokerage house lowers the price target to $108 per share from a prior target of $115. The shares have been rated Neutral. The rating by the firm was issued on August 8, 2016.

CVS Health Corporation (NYSE:CVS): The stock opened at $93.18 and touched an intraday high of $93.81 on Wednesday. During the day, the stock corrected to an intraday low of $92.857, however, the bulls stepped in and pushed the price higher to close in the green at $93.61 with a gain of 0.27% for the day. The total traded volume for the day was 3,350,385. The stock had closed at $93.36 in the previous trading session.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.